Enter your terms above and click the 'Search' button.

Showing articles 0 to 1 of 1 Filter Applied: MEK inhibitor (Click to remove) Efficacy and Safety of Selimetinib in Adults with Neurofibromatosis Type 1 and Symptomatic, Inoperable Plexiform Neurofibromas (KOMET): A Multcentre, International, Randomised Placebo-Controlled, Parallel, Double-Blind, Phase 3 Study Lancet 405:2217-2230, Chen,A.P.,et al, 2025 Showing articles 0 to 1 of 1